Cancer patients are more vulnerable to SARS-CoV-2, can experience more severe complications of COVID-19 and treatment can be delayed.
AstraZeneca on LinkedIn: Coronavirus (COVID-19) information & research hub
Analyzing the impact of the Coronavirus disease 2019 pandemic on initial oncologic presentation and treatment of non–small cell lung cancer in the United States - ScienceDirect
Coronavirus Disease COVID 19 News, Articles and Research
Frontiers Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19
化学療法-誘発性好中球減少症(CIN)治療薬の市場規模・シェア分析 -産業調査レポート -成長トレンド
Recommendations for future studies of COVID-19 in cancer patients.
The immuno-oncological challenge of COVID-19
Vaccines, Free Full-Text
Sharpless: COVID-19 expected to increase mortality by at least 10,000 deaths from breast and colorectal cancers over 10 years - The Cancer Letter
Impact of COVID‐19 on cancer patients: A review - Cavalcanti - 2021 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library